v3.26.1
Leases - Narrative (Details)
Mar. 31, 2026
USD ($)
Dec. 31, 2025
USD ($)
Mar. 31, 2025
Oct. 24, 2022
ft²
Nov. 15, 2021
ft²
renewalTerm
$ / ft²
Lessee, Lease, Description [Line Items]          
Rent increase         2.50%
Operating lease right-of-use assets $ 7,618,720 $ 8,343,832      
Weighted average remaining lease term 8 years 8 months 12 days   8 years 10 months 24 days    
Present value of remaining lease payments, percent 9.35% 9.36%      
Future minimum sublease income under noncancelable operating subleases $ 100,000        
Nephron Pharmaceuticals Corporation (“Nephron”)          
Lessee, Lease, Description [Line Items]          
Operating lease right-of-use assets 600,000        
Kindos          
Lessee, Lease, Description [Line Items]          
Operating lease right-of-use assets 1,200,000        
Recipharm          
Lessee, Lease, Description [Line Items]          
Operating lease right-of-use assets $ 1,200,000        
Wet Laboratory and Office Space          
Lessee, Lease, Description [Line Items]          
Leased area | ft²         16,903
Term of contract         157 months
Base rent per square foot | $ / ft²         33.06
Lessee, Operating Lease, Remaining Lease Term       5 years  
Square feet of office space | ft²       14,200  
Wet Laboratory and Office Space | Broadwest Lease, Five Year Renewal Option          
Lessee, Lease, Description [Line Items]          
Number of renewal terms | renewalTerm         2
Renewal term         5 years